[1] Connizzo BK, Yannascoli SM, Soslowsky LJ. Structure-function relationships of postnatal tendon development:a parallel to healing. Matrix Biol. 2013;32(2): 106-116.[2] Liu CF, Aschbacher-Smith L, Barthelery NJ, et al. What we should know before using tissue engineering techniques to repair injured tendons: a developmental biology perspective. Tissue Eng Part B Rev. 2011;17(3):165-176.[3] Benjamin M, Kaiser E, Milz S. Structure-function relationships in tendons: a review. J Anat. 2008;212(3):211-228.[4] Haggmark T, Liedberg H, Eriksson E, et al.Calf muscle atrophy and muscle function after non-operative vs operative treatment of achilles tendon ruptures. Orthopedics.1986; 9(2): 160-164.[5] Thomopoulos S, Hattersley G, Rosen V, et al. The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study.J Orthop Res. 2002;20(3):454-463. [6] Otabe K, Nakahara H, Hasegawa A, et al. The transcription factor Mohawk controls tenogenic differentiation of bone marrow mesenchymal stem cells in vitro and in vivo. J Orthop Res. 2015;33(1):1-8.[7] Aslan H, Kimelman-Bleich N, Pelled G, et al.Molecular targets for tendon neoformation. J Clin Invest. 2008;118(2):439-444.[8] Murchison ND, Price BA, Conner DA, et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development. 2007; 134(14):2697-2708.[9] 王强,曲彦隆.Scx(Scleraxis)在肌腱组织工程中的研究进展[J].中国矫形外科杂志,2015,23(12):1096-1099.[10] Niwa H, Masui S, Chambers I, et al. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol. 2002;22(5):1526-1536.[11] Ilancheran S, Moodley Y, Manuelpillai U (2009) Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta. 2009;30(1):2-10. [12] 金瑛,李豫皖,张承昊,等.体外诱导人羊膜间充质干细胞向韧带细胞分化的实验研究[J].中国修复重建外科杂志,2016,02: 237-244.[13] 方宁,张路,宋秀军,等.人羊膜间充质干细胞的分离,培养及鉴定[J].遵义医学院学报,2009,32 (03):234-236.[14] Bi Y, Ehirchiou D, Kilts TM,et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007;13(10):1219-1227.[15] BiIic G, Zeisberger SM,Mallik AS,et aI.Compative characterization of cultured human term amnion edithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant.2008:17(8):955-968.[16] 李豫皖,朱喜忠,金瑛,等.体外定向诱导人羊膜间充质干细胞向骨,软骨及脂肪细胞的分化[J].中国组织工程研究,2017,21(1): 122-127.[17] Carlberg AL, Tuan RS, Hall DJ. Regulation of scleraxis function by interaction with the bHLH protein E47. Mol Cell Biol Res Commun. 2000;3(2):82-86. [18] Hu JS, Olson EN, Kingston RE (1992) HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors.Mol Cell Biol. 1992;12(3):1031-1042.[19] Liu Y, Watanabe H, Nifuji A,et al. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells.J Biol Chem.1997;272(47):29880-29885.[20] Alberton P, Popov C, Pragert M, et al.Conversion of human bone marrow-derived mesenchymal stem cells into tendon progenitor cells by ectopic expression of scleraxis. Stem Cells Dev. 2012;21(6):846-858.[21] Comerford EJ, Tarlton JF, Innes JF, et al. Metabolism and composition of the canine anterior cruciate ligament relate to differences in knee joint mechanics and predisposition to ligament rupture. J Orthop Res. 2005;23(1):61-66. [22] Nakamura N, Hart DA, Boorman RS, et al. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J Orthop Res. 2000;18(4):517-523. [23] 朱肖奇,秦廷武,杨志明.细胞黏附基础与肌腱组织工程[J].生物医学工程学杂志,2004,21(2): 329-332.[24] 冯俊明,任勇,陈昕薇,等.胃腺癌组织中肌腱蛋白C表达的临床意义[J].华南国防医学杂志, 2014,28(11):1122-1123.[25] 安朝,徐志云.肌腱蛋白-C在急性主动脉夹层发生中的研究进展[J].第二军医大学学报, 2015,36(11); 1238-1241.[26] Jiang Y, Shi Y, He J, et al. Enhanced tenogenic differentiation and tendon-like tissue formation by tenomodulin overexpression in murine mesenchymal stem cells.J Tissue Eng Regen Med. 2017;11(9);2525-2536.[27] Schweitzer R, Chyung JH, Murtaugh LC, et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001;128 (19):3855-3866.[28] Park A, Hogan MV, Kesturu GS,et al. Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers. Tissue Eng Part A. 2010;16(9):2941-2951. |